Year-end Sale % OFF 
Abstract
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Al-Muriesh M, Liu J, Du H, et al. Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(4):806-808. doi:10.5114/ada.2022.118925. APA Al-Muriesh, M., Liu, J., Du, H., Wu, S., Wu, T., & Sun, Y. et al. (2022). Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(4), 806-808. https://doi.org/10.5114/ada.2022.118925 Chicago Al-Muriesh, Maher, Juan Liu, Hongxia Du, Shidi Wu, Ting Wu, Yanhong Sun, and Changzheng Huang. 2022. "Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 39 (4): 806-808. doi:10.5114/ada.2022.118925. Harvard Al-Muriesh, M., Liu, J., Du, H., Wu, S., Wu, T., Sun, Y., and Huang, C. (2022). Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 39(4), pp.806-808. https://doi.org/10.5114/ada.2022.118925 MLA Al-Muriesh, Maher et al. "Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 39, no. 4, 2022, pp. 806-808. doi:10.5114/ada.2022.118925. Vancouver Al-Muriesh M, Liu J, Du H, Wu S, Wu T, Sun Y et al. Daily follow-up of a scary onset of ecchymotic purpuric lesions in an infant. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2022;39(4):806-808. doi:10.5114/ada.2022.118925.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
